Please assess the completion status of the following clinical trial:

Trial Title: Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically proven adenocarcinoma of prostate with treatment of prostate cancer (radical prostatectomy, radiation therapy, etc.)~* had biochemical/clinical relapse and started on antiandrogens~* have documented history of hot flashes~Exclusion Criteria:~* History of MI, DVT, CVA~* peanut allergy~* untreated hypothyroidism~* must be off other medical treatment for hot flashes for 2 weeks before enrollment in this study

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Subjects receive supplement
- 2 (Type: PLACEBO_COMPARATOR): Subjects will receive placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).